Dysregulated RasGRP1 Responds to Cytokine Receptor Input in T Cell Leukemogenesis
Name
Chakraborty_Dysregulated.pdf
Size
1.28 MB
Format
Adobe PDF
Checksum (MD5)
f00e84eca2c8ed11943a6ce2ab9a423c
Author(s)
Yang, Ming
Govern, Christopher C.
Chakraborty, Arup K.
Hartzell, Catherine
Ksionda, Olga
Lemmens, Ed
Coakley, Kristen
Dail, Monique
Harvey, Richard C.
Bakker, Jeroen
Date Issued
March 2013
Journal
Science Signaling
Publisher
American Association for the Advancement of Science (AAAS)
Citation
Hartzell, C., O. Ksionda, E. Lemmens, K. Coakley, M. Yang, M. Dail, R. C. Harvey, et al. “Dysregulated RasGRP1 Responds to Cytokine Receptor Input in T Cell Leukemogenesis.” Science Signaling 6, no. 268 (March 26, 2013): ra21–ra21.
Version
Author's final manuscript
Abstract
Enhanced signaling by the small guanosine triphosphatase Ras is common in T cell acute lymphoblastic leukemia/lymphoma (T-ALL), but the underlying mechanisms are unclear. We identified the guanine nucleotide exchange factor RasGRP1 (Rasgrp1 in mice) as a Ras activator that contributes to leukemogenesis. We found increased RasGRP1 expression in many pediatric T-ALL patients, which is not observed in rare early T cell precursor T-ALL patients with KRAS and NRAS mutations, such as K-Ras[superscript G12D]. Leukemia screens in wild-type mice, but not in mice expressing the mutant K-Ras[superscript G12D] that encodes a constitutively active Ras, yielded frequent retroviral insertions that led to increased Rasgrp1 expression. Rasgrp1 and oncogenic K-Ras[superscript G12D] promoted T-ALL through distinct mechanisms. In K-Ras[superscript G12D] T-ALLs, enhanced Ras activation had to be uncoupled from cell cycle arrest to promote cell proliferation. In mouse T-ALL cells with increased Rasgrp1 expression, we found that Rasgrp1 contributed to a previously uncharacterized cytokine receptor–activated Ras pathway that stimulated the proliferation of T-ALL cells in vivo, which was accompanied by dynamic patterns of activation of effector kinases downstream of Ras in individual T-ALLs. Reduction of Rasgrp1 abundance reduced cytokine-stimulated Ras signaling and decreased the proliferation of T-ALL in vivo. The position of RasGRP1 downstream of cytokine receptors as well as the different clinical outcomes that we observed as a function of RasGRP1 abundance make RasGRP1 an attractive future stratification marker for T-ALL.
MIT Department
Institute for Medical Engineering and Science
Massachusetts Institute of Technology. Department of Biological Engineering
Massachusetts Institute of Technology. Department of Chemical Engineering
Massachusetts Institute of Technology. Department of Chemistry
Massachusetts Institute of Technology. Department of Physics
Terms of Use
Creative Commons Attribution-Noncommercial-Share Alike
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1126/scisignal.2003848
